Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

Ariel Israel; Matitiahu Berkovitch; Eugene Merzon; Avivit Golan-Cohen; Ilan Green; Eytan Ruppin; Shlomo Vinker; Eli Magen

doi:10.1093/cid/ciad348

Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, Avivit Golan-Cohen, Ilan Green, Eytan Ruppin, Shlomo Vinker, Eli Magen

Samson Assuta Ashdod University Hospital

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.

Original language	English
Pages (from-to)	972-975
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	77
Issue number	7
DOIs	https://doi.org/10.1093/cid/ciad348
State	Published - 1 Oct 2023

Keywords

COVID-19
G6PD deficiency
glucose-6-phosphate dehydrogenase

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciad348

Cite this

@article{c03b497eb2a04303bdfdf4850b6ef4c6,

title = "Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019",

abstract = "In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.",

keywords = "COVID-19, G6PD deficiency, glucose-6-phosphate dehydrogenase",

author = "Ariel Israel and Matitiahu Berkovitch and Eugene Merzon and Avivit Golan-Cohen and Ilan Green and Eytan Ruppin and Shlomo Vinker and Eli Magen",

year = "2023",

month = oct,

day = "1",

doi = "10.1093/cid/ciad348",

language = "English",

volume = "77",

pages = "972--975",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

AU - Israel, Ariel

AU - Berkovitch, Matitiahu

AU - Merzon, Eugene

AU - Golan-Cohen, Avivit

AU - Green, Ilan

AU - Ruppin, Eytan

AU - Vinker, Shlomo

AU - Magen, Eli

PY - 2023/10/1

Y1 - 2023/10/1

N2 - In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.

AB - In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.

KW - COVID-19

KW - G6PD deficiency

KW - glucose-6-phosphate dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=85172014878&partnerID=8YFLogxK

U2 - 10.1093/cid/ciad348

DO - 10.1093/cid/ciad348

M3 - Article

C2 - 37282346

AN - SCOPUS:85172014878

SN - 1058-4838

VL - 77

SP - 972

EP - 975

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 7

ER -

Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this